NCT00482898View on ClinicalTrials.gov

A Study of MK0359 in Patients With Chronic Asthma (0359-013)

PHASE2CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions

Asthma

Interventions

DRUG

MK0359

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00482898 - A Study of MK0359 in Patients With Chronic Asthma (0359-013) | Biotech Hunter | Biotech Hunter